No Data
No Data
5 Stocks That Could Get a Bump From Activist Investors
Sangamo Therapeutics Shares Drop 55% After Termination of Pfizer Deal
Is Pfizer Inc. (PFE) the Best Pharma Dividend Stock to Buy In 2024?
Pfizer Ends Sangamo Partnership for Hemophilia Therapy
Pfizer Options Spot-On: On December 30th, 138.38K Contracts Were Traded, With 3.31 Million Open Interest
Takeda-backed Ascentage Pharma Files for $100M IPO